Adagio Medical Holdings, Inc. (ADGM) key performance indicators and operating metrics (5 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Fulcrum-Ventricular Tachycardia Pivotal Investigational Device Exemption Trial Enrollment (Patients) | 209.00 | FY2026-Q1 |
| Acute Effectiveness (Fulcrum-Ventricular Tachycardia Trial) | 97.00 percent | FY2025-Q4 |
| Fulcrum-Ventricular Tachycardia Pivotal Study Enrollment Percentage | 85.00 percent | FY2025-Q2 |
| Fulcrum-Ventricular Tachycardia Study Patient Enrollment Target | 206.00 | FY2025-Q1 |
| Gross Margin | -1.01K percent | FY2024-Q4 |
Back to ADGM overview · ADGM earnings · ADGM holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.